Preoperative portal vein embolization for liver malignancies. 2006

P G Tarazov, and D A Granov, and V I Sergeev, and A A Polikarpov, and V N Polysalov, and E V Rozengauz
St. Petersburg Research Institute of Roentgenology and Radiation Therapy, St. Petersburg, Russia. tarazovp@mail.ru

OBJECTIVE To study effectiveness of preoperative portal vein embolization before extensive hepatic resection in patients with primary or secondary liver malignancies. METHODS Between December 1997 and May 2003, right portal vein embolization was performed in 24 patients. The indication to the procedure was a small amount (< 30%) of the future remnant liver. Ultrasound-guided percutaneous transhepatic puncture of the portal vein and embolization of its right lobar branch with Lipiodol, ethanol, gelatin sponge and/or steel coils were used. RESULTS There were no complications of the procedure. In 19-56 (mean, 30) days, CT or MRI showed significant increase of the future remnant liver volume from 25% to 35% of the whole liver; the mean increase was 40%. Laparotomy was performed in 15 patients. Right, extended right hepatectomy, and repeated resection were performed in 7, 6, and 1 patient respectively, while one patient underwent only exploration because of tumor progression. Of 14 resected patients, 11 showed no postoperative liver failure. The latter was medically cured in two of three remaining patients, while one patient (future remnant liver < 30% even after the embolization) died from liver failure in 20 days after the surgery. Hepatic resection is planning in 4 of 9 non-operated patients. The 5 patients were not operated because of tumor progression. CONCLUSIONS Right portal vein embolization is a safe and technically simple procedure that decreases the risk of postoperative hepatic failure after major liver resection.

UI MeSH Term Description Entries
D008113 Liver Neoplasms Tumors or cancer of the LIVER. Cancer of Liver,Hepatic Cancer,Liver Cancer,Cancer of the Liver,Cancer, Hepatocellular,Hepatic Neoplasms,Hepatocellular Cancer,Neoplasms, Hepatic,Neoplasms, Liver,Cancer, Hepatic,Cancer, Liver,Cancers, Hepatic,Cancers, Hepatocellular,Cancers, Liver,Hepatic Cancers,Hepatic Neoplasm,Hepatocellular Cancers,Liver Cancers,Liver Neoplasm,Neoplasm, Hepatic,Neoplasm, Liver
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011169 Portal Vein A short thick vein formed by union of the superior mesenteric vein and the splenic vein. Portal Veins,Vein, Portal,Veins, Portal
D004621 Embolization, Therapeutic A method of hemostasis utilizing various agents such as Gelfoam, silastic, metal, glass, or plastic pellets, autologous clot, fat, and muscle as emboli. It has been used in the treatment of spinal cord and INTRACRANIAL ARTERIOVENOUS MALFORMATIONS, renal arteriovenous fistulas, gastrointestinal bleeding, epistaxis, hypersplenism, certain highly vascular tumors, traumatic rupture of blood vessels, and control of operative hemorrhage. Embolotherapy,Therapeutic Embolization,Embolizations, Therapeutic,Embolotherapies,Therapeutic Embolizations
D005260 Female Females
D006498 Hepatectomy Excision of all or part of the liver. (Dorland, 28th ed) Hepatectomies
D006528 Carcinoma, Hepatocellular A primary malignant neoplasm of epithelial liver cells. It ranges from a well-differentiated tumor with EPITHELIAL CELLS indistinguishable from normal HEPATOCYTES to a poorly differentiated neoplasm. The cells may be uniform or markedly pleomorphic, or form GIANT CELLS. Several classification schemes have been suggested. Hepatocellular Carcinoma,Hepatoma,Liver Cancer, Adult,Liver Cell Carcinoma,Liver Cell Carcinoma, Adult,Adult Liver Cancer,Adult Liver Cancers,Cancer, Adult Liver,Cancers, Adult Liver,Carcinoma, Liver Cell,Carcinomas, Hepatocellular,Carcinomas, Liver Cell,Cell Carcinoma, Liver,Cell Carcinomas, Liver,Hepatocellular Carcinomas,Hepatomas,Liver Cancers, Adult,Liver Cell Carcinomas
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

P G Tarazov, and D A Granov, and V I Sergeev, and A A Polikarpov, and V N Polysalov, and E V Rozengauz
February 2007, Rozhledy v chirurgii : mesicnik Ceskoslovenske chirurgicke spolecnosti,
P G Tarazov, and D A Granov, and V I Sergeev, and A A Polikarpov, and V N Polysalov, and E V Rozengauz
September 2008, Annals of surgery,
P G Tarazov, and D A Granov, and V I Sergeev, and A A Polikarpov, and V N Polysalov, and E V Rozengauz
January 2001, Vestnik khirurgii imeni I. I. Grekova,
P G Tarazov, and D A Granov, and V I Sergeev, and A A Polikarpov, and V N Polysalov, and E V Rozengauz
September 1991, Nihon Geka Gakkai zasshi,
P G Tarazov, and D A Granov, and V I Sergeev, and A A Polikarpov, and V N Polysalov, and E V Rozengauz
October 1986, World journal of surgery,
P G Tarazov, and D A Granov, and V I Sergeev, and A A Polikarpov, and V N Polysalov, and E V Rozengauz
May 2003, Annals of surgery,
P G Tarazov, and D A Granov, and V I Sergeev, and A A Polikarpov, and V N Polysalov, and E V Rozengauz
October 2016, Gan to kagaku ryoho. Cancer & chemotherapy,
P G Tarazov, and D A Granov, and V I Sergeev, and A A Polikarpov, and V N Polysalov, and E V Rozengauz
January 2021, Journal of Cancer,
P G Tarazov, and D A Granov, and V I Sergeev, and A A Polikarpov, and V N Polysalov, and E V Rozengauz
January 2008, Annals of surgery,
P G Tarazov, and D A Granov, and V I Sergeev, and A A Polikarpov, and V N Polysalov, and E V Rozengauz
June 2013, World journal of surgical oncology,
Copied contents to your clipboard!